Maynard Um
-
-
-
-
-
-
-
European regulators accept Milestone's etripamil application for heart condition
-
-
-
-
-
-
-
Milestone Pharmaceuticals (MIST) PT Raised to $2 at Jefferies
-
-
-
-
-
-
-
Milestone Pharmaceuticals Inc. (MIST) Submits Response to the FDA’s CRL for CARDAMYST
-
-
-
-
-
-
-
Milestone Pharmaceuticals Inc. (MIST) Misses Q4 EPS by 3c
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Milestone Pharmaceuticals (MIST)
-
-
-
-
-
401,565 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

